IHI - iShares U.S. Medical Devices ETF

NYSEArca - Nasdaq Real Time Price. Currency in USD
217.01
-0.86 (-0.39%)
As of 9:49AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close217.87
Open213.86
Bid214.90 x 800
Ask219.05 x 800
Day's Range216.66 - 218.29
52 Week Range183.57 - 233.99
Volume18,257
Avg. Volume295,167
Net Assets3.66B
NAV217.98
PE Ratio (TTM)N/A
Yield0.22%
YTD Return9.12%
Beta (3Y Monthly)1.17
Expense Ratio (net)0.43%
Inception Date2006-05-01
Trade prices are not sourced from all markets
  • Healthcare's Near-Term Prospects Bright: 3 ETFs in Focus
    Zacks8 days ago

    Healthcare's Near-Term Prospects Bright: 3 ETFs in Focus

    The healthcare space might have seen a sluggish year so far. But its valuation and near-term prospects make it a good space for investments right now.

  • Best ETFs: Innovation Shines In iShares Devices Fund
    Investor's Business Daily13 days ago

    Best ETFs: Innovation Shines In iShares Devices Fund

    While biotechs and pharmaceuticals are making breakthrough discoveries, makers of medical devices are innovating too, one reason iShares U.S. Medical Devices is now one of the best ETFs.

  • 10 Top-Ranked ETFs Leading the 10-Year Bull Run
    Zackslast month

    10 Top-Ranked ETFs Leading the 10-Year Bull Run

    We have presented a bunch of top-performing ETFs of the 10-year bull market that will continue to outperform in the coming months given that these have a Zacks ETF Rank 1 (Strong Buy) or 2 (Buy).

  • ETF Trends2 months ago

    Healthcare ETF Keeps Hitting New Highs

    Just a dozen ETFs hit record highs on Friday. Extending its 2019 gains to 15%, the iShares US Medical Devices ETF (NYSEArca: IHI) was one of the ETFs hitting all-times on Friday. That as the broader healthcare ...

  • One Year of Trade Spat: 5 ETF Winners
    Zacks2 months ago

    One Year of Trade Spat: 5 ETF Winners

    Trump tariffs turned one-year old in March, causing upheaval in the global markets. But these ETFs still succeeded.

  • Analysts Are Optimistic ahead of Boston Scientific’s Q4 Results
    Market Realist3 months ago

    Analysts Are Optimistic ahead of Boston Scientific’s Q4 Results

    Analysts Are Optimistic ahead of Boston Scientific's Q4 ResultsAnalysts’ recommendations and target priceBoston Scientific (BSX) is scheduled to post its fourth-quarter and 2018 earnings results on February 6, 2019. In this article, we’ll

  • ETF Trends3 months ago

    Healthcare ETFs Slip After Abbot Lab’s Revenue Miss, Weak Outlook

    Healthcare ETFs weakened Wednesday after Abbot Laboratories (ABT) slipped on a revenue miss and revealed an uninspiring forecast for the first quarter of the new year. The Health Care Select Sector SPDR ETF (XLV) fell 0.3% on Wednesday while the S&P 500 was 0.1% lower. Abbot Laboratories' quarterly revenue fell short of expectations due to lower sales of generic drugs in the emerging markets, Reuters reports.

  • Top Performing Health Care ETFs of 2018
    Investopedia3 months ago

    Top Performing Health Care ETFs of 2018

    The health care sector spent much of 2018 as the strongest performer across the market. For investors looking to take part in the health care sector, one of the easiest and most popular options is an exchange-traded fund (ETF). Given the popularity of the health care sector ETF space and the relative success of this corner of the financial world, there were several health care ETFs which were among the top performing ETFs overall for 2018.

  • What’s Driving TransEnterix Stock on January 8?
    Market Realist3 months ago

    What’s Driving TransEnterix Stock on January 8?

    On January 8, TransEnterix (TRXC) rose 11.15% compared to its previous closing price and reached $2.99 in its pre-market trading session. On January 7, TransEnterix issued a press release announcing its preliminary operational and financial performance for the fourth quarter and fiscal 2018. Based on the closing price on January 7, TransEnterix reported returns of 9.80% in the last week, -13.50% in the last month, and -53.70% in the last quarter.

  • Best Sector of 2018 and its Hit ETFs & Stocks
    Zacks4 months ago

    Best Sector of 2018 and its Hit ETFs & Stocks

    Healthcare was the best-performing sector of 2018 and we have highlighted top-performing ETFs and stocks from this sector.

  • 10 Top-Ranked ETFs That Crushed the Market in 2018
    Zacks4 months ago

    10 Top-Ranked ETFs That Crushed the Market in 2018

    While there have been losers in most corner of the space, several ETFs still managed to end the year in green and are likely to continue outperforming in 2019 too.

  • These 3 Top Sector Plays Are Still Trouncing The Stock Market
    Investor's Business Daily4 months ago

    These 3 Top Sector Plays Are Still Trouncing The Stock Market

    What market sell-off? These three sector ETFs wrapped up 2018 with double-digit gains even though Wall Street stumbled in October and fell hard.

  • 4 Sector ETFs Surviving the Market Rout in 2018
    Zacks4 months ago

    4 Sector ETFs Surviving the Market Rout in 2018

    While most of the sectors are in red this year, a few ETFs are easily surviving the market rout.

  • A Look at the Christmas Tree of Top-Ranked ETFs
    Zacks4 months ago

    A Look at the Christmas Tree of Top-Ranked ETFs

    We have built a tree with the top-ranked ETFs that have the potential to outperform in 2019.

  • 3 Best ETF Ideas For Investors Include Dividend, China FANG Plays
    Investor's Business Daily4 months ago

    3 Best ETF Ideas For Investors Include Dividend, China FANG Plays

    Beaumont Capital Management aims to make investors comfortable by helping capture upside gains and protect against steep potential losses.

  • A Look at Medtronic’s Earnings Trends and Guidance for Fiscal 2019
    Market Realist4 months ago

    A Look at Medtronic’s Earnings Trends and Guidance for Fiscal 2019

    Medtronic (MDT) reported net income of $1.1 billion in the second quarter of fiscal 2019 compared to $2.0 billion in the second quarter of fiscal 2018. Medtronic’s net income in the first half of fiscal 2019 totaled $2.2 billion compared to $3.0 billion in the same period the prior year. Wall Street analysts anticipate that Medtronic is expected to report net income of $1.25 billion in the third quarter of fiscal 2019.

  • How Does Medtronic’s Restorative Therapies & Diabetes Group Look?
    Market Realist4 months ago

    How Does Medtronic’s Restorative Therapies & Diabetes Group Look?

    Medtronic’s Restorative Therapies Group consists of Spine, Brain, Specialty, and Pain therapies. Medtronic’s Restorative Therapies Group generated revenues of $2.0 billion in the second quarter of fiscal 2019 compared to $1.9 billion in the second quarter of fiscal 2018, reflecting ~7% YoY growth.

  • Top Sector ETFs of 2018
    Zacks4 months ago

    Top Sector ETFs of 2018

    These sector ETFs exceled in 2018 despite a few severe broader market crashes.

  • ETF Trends5 months ago

    ETFs to Help Investors Pick and Choose Their Market Exposures

    Markets have often rallied in the months after midterm elections (see chart below), but we are focused on what the new government makeup could mean for these sectors," Christopher Dhanraj, Director and Head of iShares Investment Strategy, said in a research note. Specifically, Dhanraj highlighted three U.S. segments to closely watch ahead. Something like the iShares U.S. Aerospace & Defense ETF (ITA) can be a pure play for those seeking exposure to the defense sector.

  • Wall Street Analysts Are Mostly Positive on Abiomed
    Market Realist5 months ago

    Wall Street Analysts Are Mostly Positive on Abiomed

    On November 26, Abiomed (ABMD) stock closed at $311.15, a ~3.92% rise from its previous day’s close of $299.41 on November 23. Abiomed stock rose from $187.41 at the close of market on December 29, 2017, to $311.15 at the close of market on November 26, 2018, reflecting a ~66% year-to-date rise.

  • Why Analysts Are Mostly Positive on Boston Scientific Stock
    Market Realist5 months ago

    Why Analysts Are Mostly Positive on Boston Scientific Stock

    Boston Scientific (BSX) stock rose from $24.79 at the close of market on December 29, 2017, to $34.80 at the close of market on November 23, 2018, reflecting a rise of ~40% year-to-date. On November 23, Boston Scientific stock closed at $34.80, a ~42% rise from its 52-week low of $24.54 on December 6, 2017.

  • Intuitive Surgical Stock Has Seen Growth of 34% Year-to-Date
    Market Realist5 months ago

    Intuitive Surgical Stock Has Seen Growth of 34% Year-to-Date

    Intuitive Surgical’s (ISRG) stock price rose from $364.94 at the close of market on December 29, 2017, to $489.57 on November 23, 2018, reflecting a ~34% year-to-date rise.

  • Inside General Electric’s Healthcare Business Unit Spin-Off Plan
    Market Realist5 months ago

    Inside General Electric’s Healthcare Business Unit Spin-Off Plan

    As part of its major restructuring plan, General Electric (GE) intends to spin off its Healthcare segment and turn it into a standalone entity. The company has planned the spin-off in a manner that maximizes shareholder wealth.

  • ETF Trends6 months ago

    Leveraged Healthcare ETF Gains On Midterm Election Results

    Even as the Democrats retook control of the House of Representatives and the Republicans maintained majority in the Senate, healthcare ETFs were also big winners following the 2018 Midterm Election results. ...

  • ETF Trends6 months ago

    Healthcare ETFs in Focus Ahead of Election Day

    Count the iShares US Medical Devices ETF (NYSEArca: IHI) and the iShares US Healthcare ETF (NYSEArca: IYH) among the healthcare exchange traded funds that could be affected by the results of the upcoming ...